While some analysts expect the 2025 IPO market to be relatively cool in the near-term, others anticipate more bids than in ...
The startups are the fourth and fifth drugmakers to file for initial public offerings since late December — the most notable ...
Sionna Therapeutics (SION), which is developing drugs to treat cystic fibrosis, has filed to raise $100M through an initial public offering. While Sionna (SION) didn't disclose terms in its SEC filing ...
IPO activity seems to have picked up in the U.S. with investors expecting the new Trump government to further its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback